Global Peptic Ulcer Drugs market expected to grow at CAGR of 2.9% over 2013-2018

Published on August 30, 2014 at 5:37 AM · No Comments

Research and Markets (http://www.researchandmarkets.com/research/jjj5vs/global_peptic) has announced the addition of the "Global Peptic Ulcer Drugs Market 2014-2018" report to their offering. 

A peptic ulcer is an open lesion that develops on the mucosal lining of the stomach and small intestine because of the caustic effect of the gastric acids and enzymes in these organs. The symptoms of peptic ulcers are pain in the abdomen, nausea, vomiting, and bloated stomach. The major symptoms include bleeding from the ulcer, which can be life-threatening. It is detected by bloody and sticky stools, often black in color. Peptic ulcers are caused mainly by a Helicobacter pylori infection followed by the overuse of OTC NSAIDs such as Naproxen, Aspirin and Ibuprofen. Peptic ulcers can be of two types based on the site of the ulcer: gastric ulcer and duodenal ulcer. 

The analysts forecast the Global Peptic Ulcer Drugs market to grow at a CAGR of 2.9 percent over the period 2013-2018.

This report covers the present scenario and the growth prospects of the Global Peptic Ulcer Drugs market for the period 2014-2018. To calculate the market size, the report considers the revenue generated from the sales of various drugs used in the treatment of peptic ulcers that are available in the market.

Key Topics Covered: 

01. Executive Summary

02. List of Abbreviations

03. Scope of the Report

04. Product Profiles

05. Market Research Methodology

06. Introduction

07. Market Landscape

08. Pipeline Portfolio

09. Market Segmentation by Class of Drugs

10. Geographical Segmentation

11. Buying Criteria

12. Market Growth Drivers

13. Drivers and their Impact

14. Market Challenges

15. Impact of Drivers and Challenges

16. Market Trends

17. Trends and their Impact

18. Vendor Landscape

19. Key Vendor Analysis

Companies Mentioned:

  • AstraZeneca plc
  • Eisai Co. Ltd.
  • Daewoong Pharmaceutical Co. Ltd.
  • Takeda Pharmaceutical Co. Ltd.
  • Daiichi Sankyo
  • Dr. Reddy's Laboratories
  • Eumedica
  • Ferring Pharmaceuticals
  • Horizon Pharma
  • Johnson and Johnson
  • Merck Sharp and Dohme
  • Otsuka Holdings
  • Pfizer
  • PharmaKing
  • Pozen
  • Rottapharm Madaus
  • Taiho Pharmaceutical
  • Zeria Pharmaceutical and Zuventus Healthcare
Source:

Research and Markets

Read in | English | Español | Français | Deutsch | Português | Italiano | 日本語 | 한국어 | 简体中文 | 繁體中文 | Nederlands | Русский | Svenska | Polski
Comments
The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News-Medical.Net.
Post a new comment
Post
You might also like... ×
Leg ulcer treatment to be studied by sport scientists at Sheffield Hallam University